Epithelial regulation of eicosanoid production in asthma

Pulmonary Pharmacology and Therapeutics

Volumn 25, Issue 6, 2012, Pages 432-437

  Hallstrand, Teal S ^a   Lai, Ying ^a   Henderson, William R ^a   Altemeier, William A ^a   Gelb, Michael H ^a,b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Asthma; Eicosanoid; Eosinophil; Epithelium; Exercise induced bronchoconstriction; Leukotriene; Mast cell; Phospholipase A2; Prostaglandin; Transglutaminase

Indexed keywords

ICOSANOID; LEUKOTRIENE C4; LEUKOTRIENE D4; LEUKOTRIENE E4; MUCIN; PHOSPHOLIPASE A2 GROUP X; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE 2;

ARTICLE; ENZYME RELEASE; EPITHELIUM CELL; EXERCISE INDUCED ASTHMA; LEUKOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; RESPIRATORY EPITHELIUM; SENSORY NERVE; SMOOTH MUSCLE;

ANIMALS; ASTHMA; ASTHMA, EXERCISE-INDUCED; CYSTEINE; EICOSANOIDS; EPITHELIAL CELLS; EXERCISE TEST; GROUP X PHOSPHOLIPASES A2; HUMANS; LEUKOCYTES; LEUKOTRIENES; PHOSPHOLIPASES A2, SECRETORY;

EID: 84870250996     PISSN: 10945539     EISSN: 15229629     Source Type: Journal    
DOI: 10.1016/j.pupt.2012.02.004     Document Type: Article

References (64)

1. Moore W.C., Meyers D.A., Wenzel S.E., Teague W.G., Li H., Li X., et al. Identification of asthma phenotypes using cluster analysis in the severe asthma research program. Am J Respir Crit Care Med 2010, 181:315-323.
2. Hallstrand T.S., Moody M.W., Aitken M.L., Henderson W.R. Airway immunopathology of asthma with exercise-induced bronchoconstriction. J Allergy Clin Immunol 2005, 116:586-593.
3. Hallstrand T.S., Chi E.Y., Singer A.G., Gelb M.H., Henderson W.R. Secreted phospholipase A2 group X overexpression in asthma and bronchial hyperresponsiveness. Am J Respir Crit Care Med 2007, 176:1072-1078.
4. Hallstrand T.S., Lai Y., Ni Z., Oslund R.C., Henderson W.R., Gelb M.H., et al. Relationship between levels of secreted phospholipase A groups IIA and X in the airways and asthma severity. Clin Exp Allergy 2011, 41:801-810.
5. Hendersen W.R., Oslund R.C., Bollinger J.G., Ye X., Tien Y.T., Xue J., et al. Blockade of human group X secreted phospholipase A2-induced airway inflammation and hyperresponsiveness in a mouse asthma model by a selective group X secreted phospholipase A2 inhibitor. J Biol Chem 2011.
6. 2 in allergen-induced airway inflammation and remodeling in a mouse asthma model. J Exp Med 2007, 204:865-877.
7. Hallstrand T.S., Wurfel M.M., Lai Y., Ni Z., Gelb M.H., Altemeier W.A., et al. Transglutaminase 2, a novel regulator of eicosanoid production in asthma revealed by genome-wide expression profiling of distinct asthma phenotypes. PLoS One 2010, 5:e8583.
8. Lai Y., Oslund R.C., Bollinger J.G., Henderson W.R., Santana L.F., Altemeier W.A., et al. Eosinophil cysteinyl leukotriene synthesis mediated by exogenous secreted phospholipase A2 group X. J Biol Chem 2010, 285:41491-41500.
9. Hallstrand T.S., Curtis J.R., Aitken M.L., Sullivan S.D. Quality of life in adolescents with mild asthma. Pediatr Pulmonol 2003, 36:536-543.
10. Marotel C., Natali F., Heyraud J.D., Vaylet F., L'Her P., Bonnet D., et al. Severe forms of effort-induced asthma. Allerg Immunol (Paris) 1989, 21:61-64.
11. Samee S., Altes T., Powers P., de Lange E.E., Knight-Scott J., Rakes G., et al. Imaging the lungs in asthmatic patients by using hyperpolarized helium-3 magnetic resonance: assessment of response to methacholine and exercise challenge. J Allergy Clin Immunol 2003, 111:1205-1211.
12. Becker J.M., Rogers J., Rossini G., Mirchandani H., D'Alonzo G.E. Asthma deaths during sports: report of a 7-year experience. J Allergy Clin Immunol 2004, 113:264-267.
13. Frank P.I., Morris J.A., Hazell M.L., Linehan M.F., Frank T.L. Long term prognosis in preschool children with wheeze: longitudinal postal questionnaire study 1993-2004. BMJ 2008, 336:1423-1426.
14. Stern D.A., Morgan W.J., Halonen M., Wright A.L., Martinez F.D. Wheezing and bronchial hyper-responsiveness in early childhood as predictors of newly diagnosed asthma in early adulthood: a longitudinal birth-cohort study. Lancet 2008, 372:1058-1064.
15. Joos G.F., O'Connor B., Anderson S.D., Chung F., Cockcroft D.W., Dahlen B., et al. Indirect airway challenges. Eur Respir J 2003, 21:1050-1068.
16. Cabral A.L., Conceicao G.M., Fonseca-Guedes C.H., Martins M.A. Exercise-induced bronchospasm in children: effects of asthma severity. Am J Respir Crit Care Med 1999, 159:1819-1823.
17. Carraro S., Corradi M., Zanconato S., Alinovi R., Pasquale M.F., Zacchello F., et al. Exhaled breath condensate cysteinyl leukotrienes are increased in children with exercise-induced bronchoconstriction. J Allergy Clin Immunol 2005, 115:764-770.
18. Freezer N.J., Croasdell H., Doull I.J., Holgate S.T. Effect of regular inhaled beclomethasone on exercise and methacholine airway responses in school children with recurrent wheeze. Eur Respir J 1995, 8:1488-1493.
19. Holzer K., Anderson S.D., Douglass J. Exercise in elite summer athletes: challenges for diagnosis. J Allergy Clin Immunol 2002, 110:374-380.
20. Scollo M., Zanconato S., Ongaro R., Zaramella C., Zacchello F., Baraldi E. Exhaled nitric oxide and exercise-induced bronchoconstriction in asthmatic children. Am J Respir Crit Care Med 2000, 161:1047-1050.
21. Malmberg L.P., Pelkonen A.S., Mattila P.S., Hammaren-Malmi S., Makela M.J. Exhaled nitric oxide and exercise-induced bronchoconstriction in young wheezy children - interactions with atopy. Pediatr Allergy Immunol 2009, 20:673-678.
22. Cai Y., Bjermer L., Halstensen T.S. Bronchial mast cells are the dominating LTC4S-expressing cells in aspirin-tolerant asthma. Am J Respir Cell Mol Biol 2003, 29:683-693.
23. 2 on exercise-induced bronchoconstriction in asthmatic subjects. Am J Respir Crit Care Med 1994, 149:1138-1141.
24. Duong M., Subbarao P., Adelroth E., Obminski G., Strinich T., Inman M., et al. Sputum eosinophils and the response of exercise-induced bronchoconstriction to corticosteroid in asthma. Chest 2008, 133:404-411.
25. Dougherty R.H., Sidhu S.S., Raman K., Solon M., Solberg O.D., Caughey G.H., et al. Accumulation of intraepithelial mast cells with a unique protease phenotype in T(H)2-high asthma. J Allergy Clin Immunol 2010, 125:1046-1053. e1048.
26. Woodruff P.G., Boushey H.A., Dolganov G.M., Barker C.S., Yang Y.H., Donnelly S., et al. Genome-wide profiling identifies epithelial cell genes associated with asthma and with treatment response to corticosteroids. Proc Natl Acad Sci U S A 2007, 104:15858-15863.
27. Anderson S.D., Kippelen P. Airway injury as a mechanism for exercise-induced bronchoconstriction in elite athletes. J Allergy Clin Immunol 2008, 122:225-235. quiz 236-227.
28. Hallstrand T.S., Moody M.W., Wurfel M.M., Schwartz L.B., Henderson W.R., Aitken M.L. Inflammatory basis of exercise-induced bronchoconstriction. Am J Respir Crit Care Med 2005, 172:679-686.
29. Mickleborough T.D., Lindley M.R., Ray S. Dietary salt, airway inflammation, and diffusion capacity in exercise-induced asthma. Med Sci Sports Exerc 2005, 37:904-914.
30. Meltzer S.S., Hasday J.D., Cohn J., Bleecker E.R. Inhibition of exercise-induced bronchospasm by zileuton: a 5-lipoxygenase inhibitor. Am J Respir Crit Care Med 1996, 153:931-935.
31. Melo R.E., Sole D., Naspitz C.K. Exercise-induced bronchoconstriction in children: montelukast attenuates the immediate-phase and late-phase responses. J Allergy Clin Immunol 2003, 111:301-307.
32. Pearlman D.S., van Adelsberg J., Philip G., Tilles S.A., Busse W., Hendeles L., et al. Onset and duration of protection against exercise-induced bronchoconstriction by a single oral dose of montelukast. Ann Allergy Asthma Immunol 2006, 97:98-104.
33. Philip G., Villaran C., Pearlman D.S., Loeys T., Dass S.B., Reiss T.F. Protection against exercise-induced bronchoconstriction two hours after a single oral dose of montelukast. J Asthma 2007, 44:213-217.
34. Mickleborough T.D., Lindley M.R., Ionescu A.A., Fly A.D. Protective effect of fish oil supplementation on exercise-induced bronchoconstriction in asthma. Chest 2006, 129:39-49.
35. Mickleborough T.D., Murray R.L., Ionescu A.A., Lindley M.R. Fish oil supplementation reduces severity of exercise-induced bronchoconstriction in elite athletes. Am J Respir Crit Care Med 2003, 168:1181-1189.
36. 2 to induce eicosanoid biosynthesis in neighboring inflammatory cells. J Biol Chem 2006, 281:10935-10944.
37. 2-related pathways by the Th2 cytokine IL-13. J Allergy Clin Immunol 2006, 117:1446-1454.
38. Bradding P., Redington A.E., Djukanovic R., Conrad D.J., Holgate S.T. 15-lipoxygenase immunoreactivity in normal and in asthmatic airways. Am J Respir Crit Care Med 1995, 151:1201-1204.
39. Chu H.W., Balzar S., Westcott J.Y., Trudeau J.B., Sun Y., Conrad D.J., et al. Expression and activation of 15-lipoxygenase pathway in severe asthma: relationship to eosinophilic phenotype and collagen deposition. Clin Exp Allergy 2002, 32:1558-1565.
40. Currie G.P., Haggart K., Lee D.K., Fowler S.J., Wilson A.M., Brannan J.D., et al. Effects of mediator antagonism on mannitol and adenosine monophosphate challenges. Clin Exp Allergy 2003, 33:783-788.
41. Lai Y.L., Lee S.P. Mediators in hyperpnea-induced bronchoconstriction of guinea pigs. Naunyn Schmiedebergs Arch Pharmacol 1999, 360:597-602.
42. Freed A.N., McCulloch S., Meyers T., Suzuki R. Neurokinins modulate hyperventilation-induced bronchoconstriction in canine peripheral airways. Am J Respir Crit Care Med 2003, 167:1102-1108.
43. Hallstrand T.S., Debley J.S., Farin F.M., Henderson W.R. Role of MUC5AC in the pathogenesis of exercise-induced bronchoconstriction. J Allergy Clin Immunol 2007, 119:1092-1098.
44. 2 in allergic response and parturition. Nature 1997, 390:618-622.
45. Hallstrand T.S., Henderson W.R. An update on the role of leukotrienes in asthma. Curr Opin Allergy Clin Immunol 2010, 10:60-66.
46. 2 and arachidonate increase in bronchoalveolar lavage fluid after inhaled antigen challenge in asthmatics. Am J Respir Crit Care Med 1997, 155:421-425.
47. Chilton F.H., Averill F.J., Hubbard W.C., Fonteh A.N., Triggiani M., Liu M.C. Antigen-induced generation of lyso-phospholipids in human airways. J Exp Med 1996, 183:2235-2245.
48. 2 from human nasal lavage. Am J Respir Cell Mol Biol 1994, 11:108-113.
49. 2. J Biol Chem 2002, 277:48535-48549.
50. Munoz N.M., Meliton A.Y., Arm J.P., Bonventre J.V., Cho W., Leff A.R. Deletion of secretory group V phospholipase A2 attenuates cell migration and airway hyperresponsiveness in immunosensitized mice. J Immunol 2007, 179:4800-4807.
51. Ma Y., Koza-Taylor P.H., DiMattia D.A., Hames L., Fu H., Dragnev K.H., et al. Microarray analysis uncovers retinoid targets in human bronchial epithelial cells. Oncogene 2003, 22:4924-4932.
52. Cookson W. The immunogenetics of asthma and eczema: a new focus on the epithelium. Nat Rev Immunol 2004, 4:978-988.
53. Sohn J., Kim T.I., Yoon Y.H., Kim J.Y., Kim S.Y. Novel transglutaminase inhibitors reverse the inflammation of allergic conjunctivitis. J Clin Invest 2003, 111:121-128.
54. Lee J., Kim Y.S., Choi D.H., Bang M.S., Han T.R., Joh T.H., et al. Transglutaminase 2 induces nuclear factor-kappaB activation via a novel pathway in BV-2 microglia. J Biol Chem 2004, 279:53725-53735.
55. Kim D.Y., Park B.S., Hong G.U., Lee B.J., Park J.W., Kim S.Y., et al. Anti-inflammatory effects of the R2 peptide, an inhibitor of transglutaminase 2, in a mouse model of allergic asthma, induced by ovalbumin. Br J Pharmacol 2011, 162:210-225.
56. Kim Y., Eom S., Kim K., Lee Y.S., Choe J., Hahn J.H., et al. Transglutaminase II interacts with rac1, regulates production of reactive oxygen species, expression of snail, secretion of Th2 cytokines and mediates in vitro and in vivo allergic inflammation. Mol Immunol 2010, 47:1010-1022.
57. Cowburn A.S., Sladek K., Soja J., Adamek L., Nizankowska E., Szczeklik A., et al. Overexpression of leukotriene C4 synthase in bronchial biopsies from patients with aspirin-intolerant asthma. J Clin Invest 1998, 101:834-846.
58. Macfarlane A.J., Dworski R., Sheller J.R., Pavord I.D., Kay A.B., Barnes N.C. Sputum cysteinyl leukotrienes increase 24 hours after allergen inhalation in atopic asthmatics. Am J Respir Crit Care Med 2000, 161:1553-1558.
59. 2 translocation to internal membranes. J Biol Chem 2001, 276:30150-30160.
60. 2 from cytosol to the nuclear envelope in rat basophilic leukemia cells stimulated with calcium ionophore or IgE/antigen. J Biol Chem 1995, 270:15359-15367.
61. 2-independent cysteinyl leukotriene synthesis in human eosinophils. J Biol Chem 2003, 278:38813-38820.
62. 4 in eosinophils. J Immunol 2006, 177:574-582.
63. Chilton F.H., Westcott J.Y., Zapp L.M., Henson J.E., Voelkel N.F. Incorporation of arachidonic acid into lipids of the isolated perfused rat lung. J Appl Physiol 1989, 66:2763-2771.
64. Albert C.J., Thukkani A.K., Heuertz R.M., Slungaard A., Hazen S.L., Ford D.A. Eosinophil peroxidase-derived reactive brominating species target the vinyl ether bond of plasmalogens generating a novel chemoattractant, alpha-bromo fatty aldehyde. J Biol Chem 2003, 278:8942-8950.